56 results
10-Q
2024 Q1
TCBP
TC BioPharm (Holdings) plc
15 May 24
Quarterly report
4:06pm
candidates;
costs of related office space allocated to our research and development function, materials and equipment; and
payments under our license
8-K
EX-10.1
TCBP
TC BioPharm (Holdings) plc
8 May 24
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
8:55am
or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein “SEC
10-K
2023 FY
TCBP
TC BioPharm (Holdings) plc
1 Apr 24
Annual report
5:11pm
to this approach, regulatory approval may be more complex for this genetically modified T cell therapy which effectively has two ‘starting materials’ – (i … of cellular therapy products will invariably require cryopreservation and frozen storage of cellular starting materials, intermediates and/or final product
DEF 14A
TCBP
TC BioPharm (Holdings) plc
20 Feb 24
Definitive proxy
6:05am
Materials
☐ Soliciting Material under §240.14a-12
TC BIOPHARM (HOLDINGS) PLC
(Name of Registrant as Specified in its Charter)
N/A
(Name … previously with preliminary materials.
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
TC Biopharm
PRE 14A
q257z2tlr
9 Feb 24
Preliminary proxy
3:26pm
6-K
EX-10.4
v4g v7a6e
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
424B4
jits682roy3bj7x
20 Dec 23
Prospectus supplement with pricing info
6:42pm
F-1/A
rpbutun37xe0 9rk
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-10.7
4xz4og72vavdf
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
424B3
ia5 4qycpz
8 Nov 23
Prospectus supplement
4:05pm
F-3/A
xoeasv4m evacdcs
2 Nov 23
Shelf registration (foreign) (amended)
1:11pm
6-K
EX-99.2
ilswx4ye3rsnvr1fz0
2 Nov 23
Current report (foreign)
12:57pm
F-3
j5btdtud w0xh8
29 Sep 23
Shelf registration (foreign)
4:05pm
6-K
EX-10.1
5ene6
31 Aug 23
Current report (foreign)
8:00am
F-1
4pn1nyr
28 Aug 23
Registration statement (foreign)
5:25pm
6-K
EX-99.1
mae5nkjt4lm
7 Jun 23
Current report (foreign)
4:10pm
6-K
EX-10.4
5b46pzila
30 Mar 23
TC BioPharm Announces Pricing of $5.5 Million Public Offering
5:10pm
424B4
2qt3kwc 3jgbgn2o9nns
29 Mar 23
Prospectus supplement with pricing info
5:01pm